Genzyme, Alnylam Expand Collaboration on Rare Genetic Diseases

By: Benzinga
Genzyme, a Sanofi company (NYSE: SNY ), and Alnylam Pharmaceuticals (NASDAQ: ALNY ) announced today that they have significantly expanded their strategic agreement to develop and commercialize
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.